StockData
Benitec Biopharma Inc. logo

Benitec Biopharma Inc. (BNTC) stock

BNTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$8.27+0.12 (+1.47%)

Close on Nov 18, 2026Market cap $288.48MP/E –Yield –

Benitec Biopharma free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Benitec Biopharma's free cash flow for the twelve months ending Jun 30, 2026 was -$16.62M. For fiscal 2026 it was -$16.62M. The highest annual figure on record is $4.39M in fiscal 2019.

Annual free cash flow

PeriodPeriod endValueChange
FY2026Jun 30, 2026-$16.62M–
FY2025Jun 30, 2025-$23.61M–
FY2024Jun 30, 2024-$19.58M–
FY2023Jun 30, 2023-$18.01M–
FY2022Jun 30, 2022-$15.91M–
FY2021Jun 30, 2021-$13.05M–
FY2020Jun 30, 2020-$7.63M-274.0%
FY2019Jun 30, 2019$4.39M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026-$5.02M–
Q3 FY2026CQ1 2026Mar 31, 2026-$4.47M–
Q4 FY2025CQ2 2025Jun 30, 2025-$8.21M–
Q3 FY2025CQ1 2025Mar 31, 2025-$3.09M–
Q4 FY2024CQ2 2024Jun 30, 2024-$3.29M–
Q4 FY2023CQ2 2023Jun 30, 2023-$4.10M–
Q4 FY2022CQ2 2022Jun 30, 2022-$4.87M–
Q3 FY2022CQ1 2022Mar 31, 2022-$3.42M–
Q2 FY2022CQ4 2021Dec 31, 2021-$3.34M–
Q1 FY2022CQ3 2021Sep 30, 2021-$4.28M–
Q4 FY2021CQ2 2021Jun 30, 2021-$5.02M–
Q3 FY2021CQ1 2021Mar 31, 2021-$2.00M–
Q2 FY2021CQ4 2020Dec 31, 2020-$3.50M–
Q1 FY2021CQ3 2020Sep 30, 2020-$2.53M–
Q4 FY2020CQ2 2020Jun 30, 2020-$3.16M–
Q3 FY2020CQ1 2020Mar 31, 2020-$769.00K–

More Benitec Biopharma figures

See a number that looks wrong?